Education

• 2003.08

  Doctor of Medicine : Inha University

• 1997.02

  Master of Medicine : Yonsei University

• 1988.02

  Bachelor of Medicine : Yonsei University

Career

• 1997.01 ~ present

  Professor in Pulmonary & Critical Care Medicine, Inha University Hospital

• 2003.04 ~ 2008.02

  Associate Professor in Pulmonary & Critical Care Medicine, Inha University Hospital

• 1997.04 ~ 2003.03

  Assistant Professor in Pulmonary and Critical Care Medicine, Inha Univeristy Hospital

• 2003.12 ~ 2004.12

  MayoClinic, Rochester, MN, U.S.A. Drug Center Visiting Scientist

• 1992.05 ~ 1996.02

  Resident, Wonju University Medical Center

• 1988.03 ~ 1989.02

  Intern, Severance Hospital

Professional Activities

Honors

• -

  World No Smoking Day, Minister of Health and Welfare's Mark (Ministry of Health and Welfare)

• -

  Excellent acting award (Korea Lung Cancer Society)

• -

  Marked by the Minister of Health and Medical Technology and the Minister of Welfare (MOHW)

• -

  Excellent performance award (Korea Lung Cancer Society)

• -

  Excellent thesis award (Inha University Hospital)

• -

  Travel Grant Award

• -

  Friendly Staff of the Month (Inha University Hospital)

• -

  Excellent performance award (Korea Lung Cancer Society)

• -

  The 1st Korea Cancer Society's Excellence in Essay Literature Award (Korea Cancer Society)

• -

  Meritorious Service Award (Inha University Hospital)

• -

  Excellent performance award (Korea Lung Cancer Society)

• -

  Travel Grant Award(11th World Conference of Lung Cancer, Barcelona, Spain)(세계폐암학회)

• -

  Friendly Staff of the Month (Inha University Hospital)

• -

  Excellent presentation of papers by foreign institutions (Inha University Hospital)

Research & Publications

• 2018

  Should I Have Lied

• 2016

  Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect

• 2014

  Prognostic Impact of Minimal Pleural Effusion in Non–Small-Cell Lung Cancer

• 2012

  Prognostic Biomarker in Stage I Non-Small Cell Lung Cancer Patients: Expressions of Proteins Involving in DNA Damage Response Pathway

• 2011

  Differential Effect of Polymorphisms of CMPK1 and RRM1 on Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Cisplatinum Doublets

• 2008

  Effect of BRCA1 Haplotype on Survival of Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

• 2004

  Association between Polymorphisms of ERCC1 and XPD and Survival in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin Combination Chemotherapy